Replies to post #87021 on Anavex Life Sciences Corp (AVXL)

[TomP1]

They could... but really based on a p2a with an n=32 ?
Don't think so. Would not make sense to simultaneously help Anavex in the p2/3 trial design.

[scottsmith]

Never going to happen. Let's hope the larger 2/3 starts by end of 2017.

[kld2]

have no doubt in my mind, if a large, placebo-controlled Ph2b trial demonstrates unambiguous efficacy, that FDA will approve 2-73. Though the timeline is at least a year off, based on Macfarlane's 2019 estimate. Will take at least one year to enroll 300 pts., plus one year of treatment and data analysis. Though Ph2a was a different animal, it took 10 months (January to October) to enroll 32 participants.